局所鎮痛剤の世界市場規模、シェア、成長分析：タイプ別、治療クラス別、流通チャネル別 - 産業予測（2024年～2031年）

世界の局所鎮痛剤の市場規模は、2022年に104億6,000万米ドルとなり、2023年の111億米ドルから2031年には178億8,000万米ドルに拡大し、予測期間中（2024年～2031年）にCAGR6.14%で成長すると予測されています。

局所鎮痛剤治療の市場収益増加の主な要因の1つは、関節炎の有病率の上昇です。市場拡大をさらに後押ししているのは、高齢者人口の増加とアスリートの間でのこれらのアイテムに対する強い需要です。当レポートでは、主要市場セグメント、動向、促進要因、抑制要因、競合環境、市場力学に影響を与える重要な要因の徹底的な調査を含め、世界の局所鎮痛剤市場を徹底的に評価しています。糖尿病神経障害、関節炎および関連する骨疾患、がんに関連する痛みの有病率の増加が、局所鎮痛剤市場が世界規模で急成長している主な要因です。また、経口薬に比べ副作用の少ない局所鎮痛剤の使用が増加していることも、市場拡大の原動力となっています。世界の高齢化の上昇とスポーツ選手の局所疼痛管理に対する需要の高まりも、市場拡大のさらなる要因です。しかし、外用鎮痛剤による皮膚刺激の可能性や不快な臭いなど、市場成長を制限する要因もあります。一方、外用鎮痛剤ビジネスには、外用療法のオンラインプラットフォームの出現や新興国における未開拓の可能性など、魅力的な成長機会があります。これらの要素が相まって、市場の軌跡に影響を与え、変化し続ける環境における機会と問題を浮き彫りにしています。

目次

エグゼクティブサマリー

• 市場概要
• 転変

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模の推定
• 市場の前提条件と制限

親市場の分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主な市場の考察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料の分析
• イノベーションマトリクス
• パイプライン製品の分析
• マクロ経済指標
• 主な投資の分析
• 主な成功要因
• 競合の程度

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制情勢
• ポーターの分析
• 将来の混乱についての特別な考察

局所鎮痛剤の世界市場：タイプ別

• 市場概要
• 処方箋鎮痛剤
• 市販（OTC）鎮痛剤

局所鎮痛剤の世界市場：治療クラス別

• 市場概要
• 非オピオイド
• 非ステロイド性抗炎症薬（NSAIDS）
• サリチル酸メチル
• カプサイシン
• リドカイン
• その他の非オピオイド
• オピオイド
• ブプレノルフィン
• フェンタニル

局所鎮痛剤の世界市場：流通チャネル別

• 市場概要
• 薬局・ドラッグストア
• Eコマース
• 小売店・食料品店

局所鎮痛剤の世界市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2021年）
• 主要市場企業が採用した戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア（2021年）

主要企業プロファイル

• Johnson & Johnson-USA
• GlaxoSmithKline plc-United Kingdom
• Novartis AG-Switzerland
• Pfizer Inc.-USA
• Reckitt Benckiser Group plc-United Kingdom
• Sun Pharmaceutical Industries Ltd.-India
• Endo International plc-Ireland
• Teva Pharmaceutical Industries Ltd.-Israel
• Sanofi S.A.-France
• Mylan N.V.（now part of Viatris Inc.）-USA

Global Topical Pain Relief Market size was valued at USD 10.46 billion in 2022 and is poised to grow from USD 11.10 billion in 2023 to USD 17.88 billion by 2031, growing at a CAGR of 6.14% during the forecast period (2024-2031).

One of the main factors contributing to the increased market revenue of topical pain relief treatments is the rise in the prevalence of arthritis. Further supporting market expansion are the growing geriatric population and the strong demand for these items among athletes. The report provides a thorough evaluation of the global topical pain relief market, including a thorough examination of key market segments, trends, drivers, constraints, the competitive environment, and critical factors influencing market dynamics. The increasing prevalence of diabetes neuropathy, arthritis and related bone disorders, and pain related to cancer are the main drivers of the topical pain relief market's enormous rise on a worldwide scale. The increasing use of topical painkillers, which often cause fewer negative effects than oral counterparts, is another motivating driver. The world's aging population boom and athletes' growing demand for topical pain management are two further factors driving market expansion. However, some factors, such as the possibility of skin irritation from topical painkillers and their unpleasant odour, limit the market's ability to grow. On the other hand, the topical pain relief business has attractive growth opportunities due to the emergence of online platforms for topical therapies and their unrealized potential in emerging nations. Together, these elements influence the market's trajectory, highlighting opportunities as well as problems in this ever-changing environment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segmental Analysis

The therapeutic class, type, distribution channel, formulation, and region are the factors used to segment the global market for topical pain relief. Therapeutic classes include methyl salicylate, capsaicin, lidocaine, non-opioids, opioids, buprenorphine, fentanyl, and nonsteroidal anti-inflammatory drugs (NSAIDS). The market is divided into two categories based on type: over-the-counter and prescription pain relief. The market is divided into four segments based on the distribution channel: retail, drugstore, pharmacy, and grocery store. The market is divided into cream, gel, spray, patch, and other formulation categories. The market is divided into North America, Europe, Latin America, Asia-Pacific, the Middle East, and Africa based on geographic regions.

Drivers of the Global Topical Pain Relief Market

One of the main factors driving the topical pain relief market is the rising prevalence of chronic pain problems such neuropathic pain, arthritis, and musculoskeletal illnesses. Customers are looking for convenient, focused pain relief options that are localized.

Restraints in the Global Topical Pain Relief Market

Even though topical pain relievers are widely used, more substantial clinical research is required to confirm their safety and effectiveness, which will affect consumer acceptance and confidence.

Market Trends of the Global Topical Pain Relief Market

The market is seeing a change in topical pain management solutions toward those with natural and herbal ingredients. Customers are looking for goods that are seen to be healthier and have few synthetic ingredients.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Topical Pain Relief Market by Type

• Market Overview
• Prescription Pain Relief
• Over-the-counter (OTC) Pain Relief

Global Topical Pain Relief Market by Therapeutic Class

• Market Overview
• Non-opioids
• Nonsteroidal anti-inflammatory drug (NSAIDS)
• Methyl Salicylate
• Capsaicin
• Lidocaine
• Other Non-opioids
• Opioids
• Buprenorphine
• Fentanyl

Global Topical Pain Relief Market by Distribution Channel

• Market Overview
• Pharmacy & Drug Store
• e-Commerce
• Retail & Grocery Store

Global Topical Pain Relief Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Johnson & Johnson - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc - United Kingdom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG - Switzerland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc - United Kingdom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. - Israel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (now part of Viatris Inc.) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments